ANABEL
SÁNCHEZ MARTÍN
Investigadora Predoctoral
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (9)
2023
-
Evaluation of potential targets to enhance the sensitivity of cholangiocarcinoma cells to anticancer drugs
Biomedicine and Pharmacotherapy, Vol. 168
-
Impact of tumor suppressor genes inactivation on the multidrug resistance phenotype of hepatocellular carcinoma cells
Biomedicine and Pharmacotherapy, Vol. 165
2022
-
Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems
Seminars in Liver Disease, Vol. 42, Núm. 1, pp. 087-103
2020
-
A novel serum metabolomic profile for the differential diagnosis of distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
Cancers, Vol. 12, Núm. 6
-
Molecular bases of drug resistance in hepatocellular carcinoma
Cancers, Vol. 12, Núm. 6, pp. 1-26
-
Molecular bases of mechanisms accounting for drug resistance in gastric adenocarcinoma
Cancers, Vol. 12, Núm. 8, pp. 1-29
2019
-
Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma
Cancer Drug Resistance, Vol. 2, Núm. 3, pp. 680-709
-
Role of transportome in the pharmacogenomics of hepatocellular carcinoma and hepatobiliary cancer
Pharmacogenomics, Vol. 20, Núm. 13, pp. 957-970
2018
-
Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib
Oncotarget, Vol. 9, Núm. 47, pp. 28474-28485